Uncaria tomentosa

Uncaria tomentosa, commonly known as cat's claw, is an Amazonian vine containing pentacyclic oxindole alkaloids that modulate immune function and DNA repair mechanisms. Clinical evidence shows it reduces chemotherapy-induced neutropenia and supports white blood cell recovery in cancer patients.

Origin & History

Uncaria tomentosa, commonly known as cat's claw, is a woody vine native to the Amazon rainforest belonging to the Rubiaceae family. The supplement is sourced from the inner bark, roots, or leaves of the plant, with extracts typically prepared using aqueous, hydroethanolic, or freeze-dried methods from the stem bark.

Historical & Cultural Context

Uncaria tomentosa has been used by Amazonian indigenous groups for centuries to treat inflammatory diseases, supporting its traditional role in inflammation control. It has been historically applied for immune support, wounds, and rheumatism in global traditional medicine systems.

Health Benefits

• Reduces chemotherapy-induced neutropenia and preserves white blood cell counts in breast cancer patients (moderate evidence, n=40 RCT)
• Supports DNA damage repair during cancer treatment (moderate evidence from breast cancer trial)
• May improve quality of life and reduce fatigue in advanced cancer patients (preliminary evidence, uncontrolled study)
• Provides symptom relief in osteoarthritis comparable to U. guianensis (moderate evidence, RCT)
• Demonstrates anti-inflammatory and immunomodulatory effects (preliminary evidence from preclinical meta-analyses)

How It Works

Cat's claw's pentacyclic oxindole alkaloids, particularly isopteropodine and pteropodine, enhance NF-κB signaling pathways that regulate immune cell proliferation and cytokine production. These alkaloids also activate DNA repair enzymes and reduce oxidative stress through upregulation of antioxidant pathways. The compounds selectively stimulate T-helper cell activity while modulating inflammatory responses.

Scientific Research

Clinical evidence includes a randomized trial (n=40) in breast cancer patients showing 300mg/day preserved neutrophil counts during chemotherapy (PMID: 22811748), though a similar trial in colorectal cancer patients (n=43) found no significant effects (PMID: 21869902). A phase II study reported quality of life improvements in advanced cancer patients (PMID: 25495394), while an RCT demonstrated efficacy in osteoarthritis (PMID: 11603848).

Clinical Summary

A randomized controlled trial with 40 breast cancer patients demonstrated that cat's claw supplementation significantly reduced chemotherapy-induced neutropenia and preserved white blood cell counts during treatment. The same study showed improved DNA damage repair markers and enhanced quality of life scores with reduced fatigue in advanced cancer patients. However, evidence remains limited to this single moderate-quality trial, requiring additional research to establish broader therapeutic applications. Current clinical data specifically supports its use as an adjuvant therapy during cancer treatment.

Nutritional Profile

Uncaria tomentosa (Cat's Claw) is a medicinal bark/root rather than a nutritional food source, so macronutrient content is not nutritionally significant in typical supplemental doses. Key bioactive compounds drive its pharmacological profile: Oxindole alkaloids are the primary actives, comprising 0.5–1.5% of dry bark weight, including mitraphylline (~0.089% dry weight), isomitraphylline, pteropodine, isopteropodine, speciophylline, and uncarine F — these are the immunomodulatory and DNA-repair-associated constituents. Pentacyclic oxindole alkaloids (POAs) are considered most therapeutically relevant and must be distinguished from tetracyclic oxindole alkaloids (TOAs), which may antagonize POA activity; standardized extracts typically specify ≥1.5% total alkaloids with TOA content <1%. Quinovic acid glycosides (triterpene saponins) are present at approximately 1–3% dry weight and contribute anti-inflammatory effects. Tannins (proanthocyanidins and catechins) comprise roughly 5–10% dry bark weight, contributing antioxidant capacity with an estimated ORAC value comparable to moderate-tannin plant sources. Phytosterols including beta-sitosterol are present in trace amounts (<0.1%). Carboxyl alkyl esters, particularly quinic acid derivatives, contribute to immunostimulant activity. Mineral content per typical 300mg extract dose is negligible. Bioavailability: alkaloid absorption is enhanced when taken without food; tannins may reduce alkaloid bioavailability when co-consumed with protein-rich meals; standardized POA-enriched extracts (e.g., AC-11, Vincaria) show superior clinical bioavailability over crude preparations.

Preparation & Dosage

Clinically studied dosages include 300mg/day of dry extract (typically divided into 3 doses of 100mg) for cancer support during chemotherapy cycles. Freeze-dried extracts have been used for osteoarthritis at unspecified standardized doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Green tea extract, Reishi mushroom, Astragalus, Vitamin C

Safety & Interactions

Cat's claw is generally well-tolerated but may cause mild gastrointestinal upset, dizziness, or headaches in some users. It can potentially interact with immunosuppressive medications and blood thinners due to its immune-stimulating and anticoagulant properties. Pregnant and breastfeeding women should avoid cat's claw due to insufficient safety data. Individuals with autoimmune conditions should consult healthcare providers before use as it may overstimulate immune responses.